Literature DB >> 28663252

Glucose Transporter 3 Potentiates Degranulation and Is Required for Platelet Activation.

Trevor P Fidler1, Elizabeth A Middleton1, Jesse W Rowley1, Luc H Boudreau1, Robert A Campbell1, Rhonda Souvenir1, Trevor Funari1, Nicolas Tessandier1, Eric Boilard1, Andrew S Weyrich1, E Dale Abel2.   

Abstract

OBJECTIVE: On activation, platelets increase glucose uptake, glycolysis, and glucose oxidation and consume stored glycogen. This correlation between glucose metabolism and platelet function is not well understood and even less is known about the role of glucose metabolism on platelet function in vivo. For glucose to enter a cell, it must be transported through glucose transporters. Here we evaluate the contribution of GLUT3 (glucose transporter 3) to platelet function to better understand glucose metabolism in platelets. APPROACH AND
RESULTS: Platelet-specific knockout of GLUT3 was generated by crossing mice harboring GLUT3 floxed allele to a PF4 (platelet factor 4)-driven Cre recombinase. In platelets, GLUT3 is localized primarily on α-granule membranes and under basal conditions facilitates glucose uptake into α-granules to be used for glycolysis. After activation, platelets degranulate and GLUT3 translocates to the plasma membrane, which is responsible for activation-mediated increased glucose uptake. In vivo, loss of GLUT3 in platelets increased survival in a collagen/epinephrine model of pulmonary embolism, and in a K/BxN model of autoimmune inflammatory disease, platelet-specific GLUT3 knockout mice display decreased disease progression. Mechanistically, loss of GLUT3 decreased platelet degranulation, spreading, and clot retraction. Decreased α-granule degranulation is due in part to an impaired ability of GLUT3 to potentiate exocytosis.
CONCLUSIONS: GLUT3-mediated glucose utilization and glycogenolysis in platelets promotes α-granule release, platelet activation, and postactivation functions.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  glucose; inflammation; metabolism; platelets; thrombosis

Mesh:

Substances:

Year:  2017        PMID: 28663252      PMCID: PMC5570649          DOI: 10.1161/ATVBAHA.117.309184

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  36 in total

1.  AN EFFECT OF D-GLUCOSE ON PLATELET STICKINESS.

Authors:  J M BRIDGES; A M DALBY; J H MILLAR; J A WEAVER
Journal:  Lancet       Date:  1965-01-09       Impact factor: 79.321

Review 2.  Mechanism and regulation of eukaryotic protein synthesis.

Authors:  W C Merrick
Journal:  Microbiol Rev       Date:  1992-06

3.  Munc13-4 is a limiting factor in the pathway required for platelet granule release and hemostasis.

Authors:  Qiansheng Ren; Christian Wimmer; Michael C Chicka; Shaojing Ye; Yi Ren; Frederick M Hughson; Sidney W Whiteheart
Journal:  Blood       Date:  2010-04-30       Impact factor: 22.113

4.  Interrelationships among platelet responses: studies on the burst in proton liberation, lactate production, and oxygen uptake during platelet aggregation and Ca2+ secretion.

Authors:  J W Akkerman; H Holmsen
Journal:  Blood       Date:  1981-05       Impact factor: 22.113

5.  Alpha-granule secretion from alpha-toxin permeabilized, MgATP-exposed platelets is induced independently by H+ and Ca2+.

Authors:  R Flaumenhaft; B Furie; B C Furie
Journal:  J Cell Physiol       Date:  1999-04       Impact factor: 6.384

6.  GLUT-3 (brain-type) glucose transporter polypeptides in human blood platelets.

Authors:  J D Craik; M Stewart; C I Cheeseman
Journal:  Thromb Res       Date:  1995-09-15       Impact factor: 3.944

7.  Proteomic analysis of platelet alpha-granules using mass spectrometry.

Authors:  D M Maynard; H F G Heijnen; M K Horne; J G White; W A Gahl
Journal:  J Thromb Haemost       Date:  2007-09       Impact factor: 5.824

8.  Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus.

Authors:  Paolo Gresele; Giuseppe Guglielmini; Massimiliano De Angelis; Silvia Ciferri; Marco Ciofetta; Emanuela Falcinelli; Carlo Lalli; Giovanni Ciabattoni; Giovanni Davì; Geremia B Bolli
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094

9.  Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis.

Authors:  S Lindemann; N D Tolley; D A Dixon; T M McIntyre; S M Prescott; G A Zimmerman; A S Weyrich
Journal:  J Cell Biol       Date:  2001-08-06       Impact factor: 10.539

10.  Thrombin stimulates glucose transport in human platelets via the translocation of the glucose transporter GLUT-3 from alpha-granules to the cell surface.

Authors:  H F Heijnen; V Oorschot; J J Sixma; J W Slot; D E James
Journal:  J Cell Biol       Date:  1997-07-28       Impact factor: 10.539

View more
  12 in total

1.  Glucose Metabolism Is Required for Platelet Hyperactivation in a Murine Model of Type 1 Diabetes.

Authors:  Trevor P Fidler; Alex Marti; Katelyn Gerth; Elizabeth A Middleton; Robert A Campbell; Matthew T Rondina; Andrew S Weyrich; E Dale Abel
Journal:  Diabetes       Date:  2019-02-14       Impact factor: 9.461

2.  Fueling Platelets: Where Does the Glucose Come From?

Authors:  Sidney W Whiteheart
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-09       Impact factor: 8.311

Review 3.  Highlighting Diabetes Mellitus: The Epidemic Continues.

Authors:  Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01       Impact factor: 8.311

4.  Identification of molecular mechanism and key biomarkers in membranous nephropathy by bioinformatics analysis.

Authors:  Zhaocheng Dong; Yunling Geng; Pingna Zhang; Jingyi Tang; Zijing Cao; Huijuan Zheng; Jing Guo; Chao Zhang; Baoli Liu; Wei Jing Liu
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

5.  The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming.

Authors:  Sophia M Hochrein; Hao Wu; Miriam Eckstein; Laura Arrigoni; Josip S Herman; Fabian Schumacher; Christian Gerecke; Mathias Rosenfeldt; Dominic Grün; Burkhard Kleuser; Georg Gasteiger; Wolfgang Kastenmüller; Bart Ghesquière; Jan Van den Bossche; E Dale Abel; Martin Vaeth
Journal:  Cell Metab       Date:  2022-03-21       Impact factor: 31.373

6.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

7.  Nox2 NADPH oxidase is dispensable for platelet activation or arterial thrombosis in mice.

Authors:  Vijay K Sonkar; Rahul Kumar; Melissa Jensen; Brett A Wagner; Anjali A Sharathkumar; Francis J Miller; MaryBeth Fasano; Steven R Lentz; Garry R Buettner; Sanjana Dayal
Journal:  Blood Adv       Date:  2019-04-23

8.  It takes a village: lessons from collaborative science.

Authors:  E Dale Abel
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

9.  A Multivariate Metabolomics Method for Estimating Platelet Mitochondrial Oxygen Consumption Rates in Patients with Sepsis.

Authors:  Marc R McCann; Cora E McHugh; Maggie Kirby; Theodore S Jennaro; Alan E Jones; Kathleen A Stringer; Michael A Puskarich
Journal:  Metabolites       Date:  2020-04-02

10.  Analysis of glucose metabolism by 18F-FDG-PET imaging and glucose transporter expression in a mouse model of intracerebral hemorrhage.

Authors:  Xiaoning Han; Honglei Ren; Ayon Nandi; Xuanjia Fan; Raymond C Koehler
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.